نتایج جستجو برای: chemoimmunotherapy

تعداد نتایج: 698  

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006
Apostolia-Maria Tsimberidou Susan O'Brien Issa Khouri Francis J Giles Hagop M Kantarjian Richard Champlin Sijin Wen Kim-Anh Do Susan C Smith Susan Lerner Emil J Freireich Michael J Keating

PURPOSE The purpose of this study was to assess the incidence, presenting characteristics, and treatment outcomes of Richter's syndrome (RS) and factors predicting response and survival. PATIENTS AND METHODS An electronic database search of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who presented at The University of Texas M.D. Anderson Cancer Center (Ho...

Journal: :Cancer research 1986
E Schlick P Hewetson R Ruffmann

Starting from the observation that success of combined treatment of MBL-2 tumor-bearing mice with the alkylating agent cyclophosphamide (CY; 150 mg/kg) and the immunomodulator maleic anhydride divinyl either copolymer (MVE-2; 25 mg/kg) was dependent upon a 1-3-day interval between treatment with CY and MVE-2, we have further analyzed in vitro and in vivo the relationship between tumor burden an...

Journal: :Blood 2016
Carmen Diana Herling Marion Klaumünzer Cristiano Krings Rocha Janine Altmüller Holger Thiele Jasmin Bahlo Sandra Kluth Giuliano Crispatzu Marco Herling Joanna Schiller Anja Engelke Eugen Tausch Hartmut Döhner Kirsten Fischer Valentin Goede Peter Nürnberg Hans Christian Reinhardt Stephan Stilgenbauer Michael Hallek Karl-Anton Kreuzer

Genetic instability is a feature of chronic lymphocytic leukemia (CLL) with adverse prognosis. We hypothesized that chromosomal translocations or complex karyotypes and distinct somatic mutations may impact outcome after first-line chemoimmunotherapy of CLL patients. We performed metaphase karyotyping and next-generation sequencing (NGS) of 85 genes in pretreatment blood samples obtained from 1...

Journal: :Blood 2016
Philip A Thompson Constantine S Tam Susan M O'Brien William G Wierda Francesco Stingo William Plunkett Susan C Smith Hagop M Kantarjian Emil J Freireich Michael J Keating

Accurate identification of patients likely to achieve long-progression-free survival (PFS) after chemoimmunotherapy is essential given the availability of less toxic alternatives, such as ibrutinib. Fludarabine, cyclophosphamide, and rituximab (FCR) achieved a high response rate, but continued relapses were seen in initial reports. We reviewed the original 300 patient phase 2 FCR study to ident...

2015
Baofa Yu Yuanfei Lu Feng Gao Peng Jing Han Wei Peicheng Zhang Guoliang Liu Ning Ru Guanghui Cui Xinhai Xu Chenglin Sun Changjiang Guan Yebing Che Yingli Wu Zhenlu Ma Qiang Fu Jian Liu Huan-You Wang

AIM The objective of the study reported here was to evaluate the therapeutic effects of hapten-enhanced chemoimmunotherapy in the treatment of advanced lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy (UMIPIC) and to analyze the effect of this immune booster. MATERIALS AND METHODS A total of 97 patients with advanced lung cancer were treated with UMIPIC or in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید